Healthcare Services

Advancements in multi-gene testing are driving the expanded carrier screening market

April 21, 2026April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Expanded Carrier Screening Market Expected To Change From 2026 To 2030?

The expanded carrier screening market size has seen rapid development in recent years. It is forecast to grow from $2.46 billion in 2025 to $2.87 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.7%. This historical growth can be attributed to heightened awareness of inherited genetic disorders, the expansion of prenatal screening programs, advancements in genetic sequencing accuracy, an increasing availability of diagnostic laboratories, and rising clinician adoption of carrier screening tools.

The expanded carrier screening market size is anticipated to experience substantial growth in the upcoming years. It is projected to reach $5.28 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 16.4%. This expansion during the forecast period is primarily driven by an increasing demand for personalized reproductive health solutions, the rising integration of AI-based variant interpretation, the broadening of population-wide screening initiatives, growing investments in genomic data platforms, and an increased focus on preventive genetic healthcare. Major developments expected over this period include the rising adoption of pan-ethnic genetic screening panels, an escalating demand for preconception carrier testing, the increasing utilization of next-generation sequencing technologies, the expansion of direct-to-provider genetic testing services, and an enhanced emphasis on genetic counseling integration.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/expanded-carrier-screening-global-market-report

What Leading Drivers Are Supporting The Expanded Carrier Screening Market Expansion?

The expanding incidence of genetic disorders is anticipated to fuel the development of the expanded carrier screening market in the coming years. Genetic diseases are conditions stemming from irregularities or alterations in an individual’s DNA, which can be passed down through generations or manifest spontaneously. The increased occurrence of genetic diseases is attributed to breakthroughs in diagnostic techniques, especially next-generation sequencing and other genomic instruments, which have substantially enhanced the capacity to identify and characterize numerous genetic conditions that were previously undetected or incorrectly categorized. Expanded carrier screening plays a crucial role in identifying individuals who carry genetic disorders before symptoms emerge, thus facilitating well-informed reproductive choices and mitigating the danger of transmitting inherited conditions to future offspring. As an illustration, in October 2024, data from the Cystic Fibrosis Trust, a UK-based charity committed to assisting individuals with cystic fibrosis, showed that 11,148 cystic fibrosis patients were recorded in 2022, a figure that climbed to 11,318 in 2023, representing a 1.5% year-over-year increase in patient registrations. Consequently, the increasing prevalence of genetic diseases is a key factor boosting the growth of the carrier screening market.

How Are Different Segments Classified In The Expanded Carrier Screening Market Segment Analysis?

The expanded carrier screening market covered in this report is segmented –

1) By Type: Customized Panel Testing, Predesigned Panel Testing

2) By Technology: Deoxyribonucleic Acid Sequencing, Polymerase Chain Reaction, Microarrays, Other Technologies

3) By Application: Preconception, Prenatal, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Research Laboratories, Specialty Clinics, Other End-Users

Subsegments:

1) By Customized Panel Testing: Single Gene Testing, Multi-Gene Panel Testing, Ethnicity-Based Custom Panels, Condition-Specific Custom Panels, Family History-Based Custom Panels

2) By Predesigned Panel Testing: Pan-Ethnic Panels, Universal Carrier Panels, Population-Specific Panels, Disorder-Focused Panels, Expanded Predefined Panels

What Emerging Trends Are Seen In The Expanded Carrier Screening Market?

Major companies operating in the Expanded Carrier Screening Market are concentrating on developing innovative solutions, such as comprehensive next-generation sequencing-based panels, to detect a broad spectrum of genetic conditions with enhanced accuracy and efficiency. These comprehensive next-generation sequencing (NGS)-based panels are sophisticated genetic tests that analyze multiple genes simultaneously to identify a wide range of inherited disorders with high accuracy and speed. For instance, in February 2023, Fulgent Genetics Inc., a US-based genomic testing company, launched the Beacon787 Expanded Carrier Screening Panel, specifically designed to evaluate 787 genes linked to severe inherited conditions. This panel offers extensive coverage for over 700 autosomal recessive and X-linked disorders, including all Tier 3 genes. It leverages advanced next-generation sequencing technology, providing high analytical accuracy, a pan-ethnic approach, and a quick turnaround time of 2–3 weeks, positioning it as one of the most comprehensive and precise reproductive carrier screening solutions available.

Who Are The Companies Driving Activity In The Expanded Carrier Screening Market?

Major companies operating in the expanded carrier screening market are Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific SE, Illumina Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., BGI Genomics Co. Ltd., Ambry Genetics Corporation, GeneDx Inc., BillionToOne Inc., MedGenome Labs Ltd., Centogene N.V., Baylor Miraca Genetics Laboratories LLC, Victorian Clinical Genetics Services, Pathkind Diagnostics Private Limited, Medicover Genetics GmbH, NxGen MDx LLC, GeneTech

Get The Full Expanded Carrier Screening Market Report:

https://www.thebusinessresearchcompany.com/report/expanded-carrier-screening-global-market-report

Which Region Holds The Highest Market Share In The Expanded Carrier Screening Market?

North America was the largest region in the expanded carrier screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the expanded carrier screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Expanded Carrier Screening Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/expanded-carrier-screening-global-market-report

Browse Through More Reports Similar to the Global Expanded Carrier Screening Market 2026, By The Business Research Company

Cellular Health Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellular-health-screening-global-market-report

Security Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/security-screening-global-market-report

Wireless Telecommunication Carrier Market Report 2026

https://www.thebusinessresearchcompany.com/report/wireless-telecommunication-carrier-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795